Richard E. Layton, M.D. Banned from Using Chelation Therapy
In 2013, the Maryland State Board of Physicians charged Richard E. Layton, M.D. with failing to meet appropriate standards of care in his management of seven pediatric patients. The consent order (shown below) indicates that the board was concerned with his inappropriate use of (a) chelation therapy, (b) intravenous glutathione, (c) intravenous secretin, (d) ketoconazole (an antifungal medication), (e) Zithromax (an antibiotic), (f) methyl B2 injections, (g) low-dose allergy injections, (h) intravenous vitamin C, (i) other dietary supplements, and (j) various dietary restrictions. Six of the patients had been diagnosed as autistic. The seventh patient began seeing Layton at age 7 months because the parents were concerned that he might be autistic, but a pediatric neurologist later determined that he was not. The case was …
Continue Reading >
